Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Hugues Trouvin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Biotechnology Advances|February 27, 2007
Introductory note to the three-part series of papers by Basant Sharma on: immunogenicity of therapeutic proteins: how to assess and the role of pharmaceutical qualityJean-Hugues Trouvin
La Revue Du Praticien|January 20, 2006
[Viral safety concept: application to blood and blood products]Jean-Hugues Trouvin
Bulletin De L'Academie Nationale De Medecine|April 3, 2003
[Sanitary safety of GMOs used in therapeutics]Jean-Hugues Trouvin
Advances in Experimental Medicine and Biology|September 17, 2015
Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy ProductsSophie Lucas-Samuel, Nicolas Ferry, Jean-Hugues Trouvin
Health Affairs (Project Hope)|October 9, 2013
Biosimilars and the European experience: implications for the United StatesFrancis Megerlin, Ruth Lopert, Ken Taymor, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 14, 2014
Demonstration of biosimilarity, extrapolation of indications and other challenges related to biosimilars in EuropeAsterios S Tsiftsoglou, Jean Hugues Trouvin, Gonzalo Calvo, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|August 28, 2018
[Regulatory science in public health: What are we talking about?]Marie Camadro, Daniel Benamouzig, Robert Barouki, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 11, 2017
Scientific considerations for the regulatory evaluation of cell therapy productsJohn Petricciani, Takao Hayakawa, Glyn Stacey, et al.
Hormone Research|December 7, 2007
Similar biological medicinal products containing recombinant human growth hormone: European regulationMira Pavlovic, Elizabeth Girardin, Liliana Kapetanovic, et al.
Bulletin Du Cancer|November 12, 2003
[Regulatory framework of cell therapy products]Saliha Moussaoui, Sophie Lucas, Pierette Zorzi, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Biotechnology Advances|February 27, 2007
Introductory note to the three-part series of papers by Basant Sharma on: immunogenicity of therapeutic proteins: how to assess and the role of pharmaceutical qualityJean-Hugues Trouvin
La Revue Du Praticien|January 20, 2006
[Viral safety concept: application to blood and blood products]Jean-Hugues Trouvin
Bulletin De L'Academie Nationale De Medecine|April 3, 2003
[Sanitary safety of GMOs used in therapeutics]Jean-Hugues Trouvin
Advances in Experimental Medicine and Biology|September 17, 2015
Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy ProductsSophie Lucas-Samuel, Nicolas Ferry, Jean-Hugues Trouvin
Health Affairs (Project Hope)|October 9, 2013
Biosimilars and the European experience: implications for the United StatesFrancis Megerlin, Ruth Lopert, Ken Taymor, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 14, 2014
Demonstration of biosimilarity, extrapolation of indications and other challenges related to biosimilars in EuropeAsterios S Tsiftsoglou, Jean Hugues Trouvin, Gonzalo Calvo, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|August 28, 2018
[Regulatory science in public health: What are we talking about?]Marie Camadro, Daniel Benamouzig, Robert Barouki, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 11, 2017
Scientific considerations for the regulatory evaluation of cell therapy productsJohn Petricciani, Takao Hayakawa, Glyn Stacey, et al.
Hormone Research|December 7, 2007
Similar biological medicinal products containing recombinant human growth hormone: European regulationMira Pavlovic, Elizabeth Girardin, Liliana Kapetanovic, et al.
Bulletin Du Cancer|November 12, 2003
[Regulatory framework of cell therapy products]Saliha Moussaoui, Sophie Lucas, Pierette Zorzi, et al.
Pageof 4